Progressive histone alterations and proinflammatory gene activation: Consequences of heme protein/iron-mediated proximal tubule injury

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 3, 2010, Pages

  Zager, Richard A ^a   Johnson, Ali C M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

H2A.Z; H3K4m3; Heme oxygenase 1; Monocyte chemoattractant protein 1; Rhabdomyolysis; RNA polymerase II; TNF ; Transforming growth factor 1

Indexed keywords

GLYCEROL; HEMOPROTEIN; HISTONE; IRON; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA POLYMERASE II; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOLYSIS; RNA TRANSCRIPTION; UREA NITROGEN BLOOD LEVEL;

EID: 77649158373     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00683.2009     Document Type: Article

References (49)

1. Asirvatham AJ, Gregoried CJ, Zihua H, Magner WJ, Tomasi TB. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol 45: 1995-2006, 2008.
2. Baliga R, Zhang Z, Baliga M, Ueda N, Shas SV. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 54: 15623-1569, 1998.
3. Baliga R, Zhang M, Shah SV. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49: 362-369, 1996.
4. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181, 2005.
5. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS, Crawford GE. High-resolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322, 2008.
6. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 43: 559-599, 2009.
7. El Gazzar M, Liu T, Yoza BK, McCall CE. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J Biol Chem 285: 1259-1271, 2010.
8. Furlan D, Sahnane N, Carnevali I, Cerutti R, Uccella S, Bertolini V, Chiaravalli AM, Capella C. Up-regulation and stabilization of HIF-1α in colorectal carcinomas. Surg Oncol 16: S25-S27, 2007.
9. Hayworth JL, Kasper KJ, Leon-Ponte M, Herfst CA, Yue D, Brintnell WC, Mazzuca DM, Heinrichs DE, Cairns E, Madrenas J, Hoskin DW, McCormick JK, Haeryfar SM. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin. Clin Exp Immunol 157: 60-70, 2009.
10. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318, 2007.
11. Hirose S. Crucial roles for chromatin dynamics in cellular memory. J Biochem (Tokyo) 141: 615-619, 2007.
12. Hon GC, Hawkins RD, Ren BL. Predictive chromatin signatures in the mammalian genome. Hum Mol Genet 18: R195-R201, 2009.
13. Ibrahim H, Lee YJ, Curthoys NP. Renal response to metabolic acidosis: role of mRNA stabilization. Kidney Int 73: 11-18, 2008.
14. John S, Sabo PJ, Johnson TA, Sung MH, Biddie SC, Lightman SL, Voss TC, Davis SR, Meltzer PS, Stamatoyannopoulos JA. Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell 29: 611-624, 2008.
15. Kanakiriya SK, Croatt AJ, Haggard JJ, Ingelfinger JR, Tang SS, Alam J, Nath KA. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol 284: F546-F554, 2003.
16. Kornberg RD. The molecular basis of eukaryotic transcription. Proc Natl Acad Sci USA 104: 12955-12961, 2007.
17. Kouzarides T. Chromatin modifications and their function. Cell 128: 693-705, 2007.
18. Lee HT, Park SW, Kim M, D'Agati VD. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest 89: 196-208, 2009.
19. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 128: 707-719, 2007.
20. Lin H, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004.
21. Marx J. Transcription enzyme structure solved. Science 292: 411-414, 2001.
22. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703, 2009.
23. Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet 22: 320-329, 2006.
24. Naito M, Bomsztyk K, Zager RA. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J Am Soc Nephrol 19: 1321-30, 2008.
25. Naito M, Bomsztyk K, Zager RA. Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene. Am J Pathol 174: 54-62, 2009.
26. Naito M, Zager RA, Bomsztyk K. BRG1 increases transcription of proinflammatory genes in renal ischemia. J Am Soc Nephrol 20: 1787-1796, 2009.
27. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006.
28. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90: 267-270, 1992.
29. Nath KA, Croatt AJ, Haggard JJ, Grande JP. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 57: 2423-2433, 2000.
30. Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 53: 100-111, 1998.
31. Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, Alam J. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 59: 106-117, 2001.
32. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 1: 179-185, 2006.
33. Nelson JD, Flanagin S, Kawata Y, Denisenko O, Bomsztyk, K. Transcription of laminin G1 chain gene in rat mesangial cells: constitutive and inducible RNA polymerase II recruitment and chromatin states. Am J Physiol Renal Physiol 294: F525-F533, 2008.
34. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57, 1994.
35. Shah SV. Oxidants and iron in progressive kidney disease. J Ren Nutr 16: 185-189, 2006.
36. Shivaswamy S, Bhinge A, Zhao Y, Jones S, Hirst M, Iyer VR. Dynamic remodeling of individual nucleosomes across a eukaryotic genome in response to transcriptional perturbation. PLoS Biol 6: xve65, 2008.
37. Shulman LM, Yuhas Y, Frolkis I, Gavendo S, Knecht A, Eliahou HE. Glycerol-induced ARF in rats is mediated by tumor necrosis factor-α. Kidney Int 43: 1397-1401, 1993.
38. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18: 414-420, 2007.
39. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
40. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Physiol Renal Physiol 285: F208-F218, 2003.
41. Yang J, Park Y, Zhang H, Gao X, Wilson E, Zimmer W, Abbott L, Zhang C. Role of MCP1 in tumor necrosis factor-α-induced endothelial dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 297: H1208-H1216, 2009.
42. Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 90: 711-719, 1992.
43. Zager RA:. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49: 314-326, 1996.
44. Zager RA. Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. Kidney Int 68: 1533-1542, 2005.
45. Zager RA, Johnson AC. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/ profibrotic genes. Am J Physiol Renal Physiol 296: F1032-F1041, 2009.
46. Zager RA, Johnson AC, Hanson SY. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int 66: 144-156, 2004.
47. Zager RA, Johnson AC, Hanson SY, Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-α generation and systemic release. Am J Physiol Renal Physiol 289: F289-F297, 2005.
48. Zager RA, Johnson AC, Hanson SY, Wasse H. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 40: 90-103, 2002.
49. Zager RA, Johnson AC, Naito M, Bomsztyk K. Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death. Am J Physiol Renal Physiol 294: F187-F197, 2008.